Prostate cancer
RecruitingStudy on the Effect of Metastasis-Directed Therapy with Lutetium (177Lu) Zadavotide Guraxetan in Patients with Advanced Prostate Cancer and Up to 5 Progressive Lesions
Study on the Effect of Metastasis-Directed Therapy with Lutetium (177Lu) Zadavotide Guraxetan in Patients with Advanced Prostate Cancer and Up to 5 Progressive Lesions
- Disease:Prostate cancer
- Substances:Abiraterone AcetateApalutamide+9
Belgium- Participants:18–64 years · 65+ years
- Substances:Abiraterone Acetate
- Sponsor:UZ Leuven










